Symbiotec’s R&D uses State-of-the-art Technologies to develop new Generic APIs and innovative and optimized processes for our existing products. Our mission is to create compliance-focused regulatory processes for pharmaceutical products and fully backward integrated to serve diverse markets worldwide.
The R&D team is composed of highly qualified scientists, including post-doctorates, Ph.D. holders, and post-graduates. The team is dedicated to developing complex APIs using chemical synthesis, biotechnology, analytical, regulatory, and intellectual property expertise.
Our team constantly keeps focusing on the economic viability, robustness, and scalability of processes. We also work in collaboration with International Research Institutions that boost our research capabilities.
Symbiotec swears by green chemistry and has been a frontrunner in fields like biotransformation, bio-catalysis, and fermentation, offering their best care to the environment for over a decade.
